🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Multiple myeloma (MM) is an incurable malignancy and accounts for 1 percent...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-06-18
Trial ID
NCT03525678
Treatments Being Tested
This is a phase 1/2, open label, single-center study designed to assess the...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2022-10-20
Trial ID
NCT05581875
Treatments Being Tested
Multiple myeloma (MM) is a neoplastic plasma cell disorder that is characte...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-12-09
Trial ID
NCT04177823
Treatments Being Tested
This is a phase 1/2, open label, study designed to assess the safety and cl...
Status
Unknown
Location
Department of Clinical Therapeutics, School of Medicine, National Kapodistrian University of Athens (NKUA)
Start Date
2022-04-13
Trial ID
NCT05280275
Treatments Being Tested
Belantamab mafodotin is an antibody-drug conjugate (ADC) containing humaniz...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2020-10-09
Trial ID
NCT04398745
Treatments Being Tested
This is a phase 1/2, open-label study designed to assess the safety and cli...
Status
Recruiting
Location
General Hospital of Athens "Alexandra", NKUA, Therapeutic Clinic
Start Date
2023-07-14
Trial ID
NCT05573802
Treatments Being Tested